Rituximab in rheumatic diseases
- 31 January 2007
- journal article
- editorial
- Published by Elsevier BV in Joint Bone Spine
- Vol. 74 (1), 4-6
- https://doi.org/10.1016/j.jbspin.2006.08.002
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- The efficacy and safety of rituximab in patients with active rheumatoid arthritis despite methotrexate treatment: Results of a phase IIB randomized, double‐blind, placebo‐controlled, dose‐ranging trialArthritis & Rheumatism, 2006
- Reconstitution of peripheral blood B cells after depletion with rituximab in patients with rheumatoid arthritisArthritis & Rheumatism, 2006
- Rituximab treatment for glomerulonephritis in HCV-associated mixed cryoglobulinaemia: efficacy and safety in the absence of steroidsRheumatology, 2006
- B-cell depletion in the treatment of patients with systemic lupus erythematosus: a longitudinal analysis of 24 patientsRheumatology, 2005
- Rituximab treatment in patients with primary Sjögren's syndrome: An open‐label phase II studyArthritis & Rheumatism, 2005
- B Lymphocytes Are Required for Development and Treatment of Autoimmune DiseasesAnnals of the New York Academy of Sciences, 2005
- Nine patients with anti‐neutrophil cytoplasmic antibody‐positive vasculitis successfully treated with rituximabJournal of Internal Medicine, 2005
- Remission of proliferative lupus nephritis following B cell depletion therapy is preceded by down‐regulation of the T cell costimulatory molecule CD40 ligand: An open‐label trialArthritis & Rheumatism, 2005
- B cell depletion as a novel treatment for systemic lupus erythematosus: A phase I/II dose‐escalation trial of rituximabArthritis & Rheumatism, 2004
- An open study of B lymphocyte depletion in systemic lupus erythematosusArthritis & Rheumatism, 2002